{"disease":{"id":"alopecia-androgenetic","name":"alopecia androgenetic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06648850","title":"Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":1120,"lead_sponsor_name":"Applied Biology, Inc.","has_results":false},{"nct_id":"NCT05914805","title":"A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":762,"lead_sponsor_name":"Cassiopea SpA","has_results":false},{"nct_id":"NCT03004469","title":"Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":458,"lead_sponsor_name":"Polichem S.A.","has_results":true},{"nct_id":"NCT07529977","title":"Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":372,"lead_sponsor_name":"Eurofarma Laboratorios S.A.","has_results":false},{"nct_id":"NCT07516561","title":"Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":336,"lead_sponsor_name":"Apsen Farmaceutica S.A.","has_results":false},{"nct_id":"NCT06263413","title":"Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"AI Labs Group S.L","has_results":false},{"nct_id":"NCT07076706","title":"Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Beijing Dayspring Pharmaceutical Technology Co., Ltd","has_results":false},{"nct_id":"NCT03154528","title":"Role of Vitamin D in Androgenetic Alopecia","phase":"","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05802173","title":"Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"Technoderma Medicines Inc.","has_results":true},{"nct_id":"NCT06764329","title":"The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.","phase":"PHASE1, PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":70,"lead_sponsor_name":"National Institute of Blood and Marrow Transplant (NIBMT), Pakistan","has_results":false},{"nct_id":"NCT06854432","title":"Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia","phase":"NA","overall_status":"TERMINATED","enrollment_count":46,"lead_sponsor_name":"Pierre Fabre Dermo Cosmetique","has_results":false},{"nct_id":"NCT07038941","title":"Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Beijing Dayspring Pharmaceutical Technology Co., Ltd","has_results":false},{"nct_id":"NCT05296863","title":"Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Dr. dr. Lili Legiawati, SpKK(K)","has_results":false},{"nct_id":"NCT05244980","title":"A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Technoderma Medicines Inc.","has_results":false},{"nct_id":"NCT04913519","title":"A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Technoderma Medicines Inc.","has_results":false},{"nct_id":"NCT07011485","title":"A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":15,"lead_sponsor_name":"PDFE Pharma Innovations FZCO","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}